CLINICAL_TRIALS
withdrawal
· 2015-07-16
Clinical Trial Update: Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005) [Phase 3]
Summary
Bayer’s Phase 3 trial MK-8114-005 evaluating polyethylene glycol 3350 (PEG 3350) for relief of constipation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Constipation | Phase 3 | Status: WITHDRAWN